2007
DOI: 10.1185/030079907x199565
|View full text |Cite
|
Sign up to set email alerts
|

Bosentan treatment in chronic pulmonary venous hypertension with significant right heart dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Diuretics and levosimendan led to a substantial improvement of diastolic left heart function. Our own experience of beneficial effects of pulmonary vascular dilative medical therapy with bosentan in patients with heart failure with a normal ejection fraction with PVH and right ventricular failure [ 19 ] led us to consider the application of an endothelin-1-receptor antagonist in this case. In addition a therapy with epoprostenol, of which beneficial effects on reversibility of pulmonary hypertension in congestive heart failure prior to cardiac transplantation are known, was started [ 8 , 20 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…Diuretics and levosimendan led to a substantial improvement of diastolic left heart function. Our own experience of beneficial effects of pulmonary vascular dilative medical therapy with bosentan in patients with heart failure with a normal ejection fraction with PVH and right ventricular failure [ 19 ] led us to consider the application of an endothelin-1-receptor antagonist in this case. In addition a therapy with epoprostenol, of which beneficial effects on reversibility of pulmonary hypertension in congestive heart failure prior to cardiac transplantation are known, was started [ 8 , 20 22 ].…”
Section: Discussionmentioning
confidence: 99%